APA (7th ed.) Citation

Spellberg, B., Marr, K. A., & Brass, E. P. (2016). Regulatory Pathways for New Antimicrobial Agents: Trade-offs to Keep the Perfect From Being the Enemy of the Good. Clinical pharmacology and therapeutics, 100(6), 597. https://doi.org/10.1002/cpt.510

Chicago Style (17th ed.) Citation

Spellberg, B., K A. Marr, and E P. Brass. "Regulatory Pathways for New Antimicrobial Agents: Trade-offs to Keep the Perfect From Being the Enemy of the Good." Clinical Pharmacology and Therapeutics 100, no. 6 (2016): 597. https://doi.org/10.1002/cpt.510.

MLA (9th ed.) Citation

Spellberg, B., et al. "Regulatory Pathways for New Antimicrobial Agents: Trade-offs to Keep the Perfect From Being the Enemy of the Good." Clinical Pharmacology and Therapeutics, vol. 100, no. 6, 2016, p. 597, https://doi.org/10.1002/cpt.510.